Literature DB >> 20930309

Evaluation of intrathecal serum amyloid P (SAP) and C-reactive protein (CRP) synthesis in Alzheimer's disease with the use of index values.

Sandra D Mulder1, C Erik Hack, Wiesje M van der Flier, Philip Scheltens, Marinus A Blankenstein, Robert Veerhuis.   

Abstract

Serum amyloid P (SAP) and C-reactive protein (CRP) are proteins involved in innate immunity. The expression of SAP and CRP is increased in Alzheimer's disease (AD) brain tissue, compared to healthy controls. Although both proteins are found in cerebrospinal fluid (CSF), their origin is unclear. We investigated if increased local production of SAP and CRP in AD brain results in higher levels in CSF with the use of index values. To study this, SAP, CRP, and albumin levels were determined in CSF and serum samples of 30 control (65 ± 11 years; 57% female) and 140 AD subjects (65 ± 9 years; 53% female). To correct for inter-individual differences in protein diffusion from blood to CSF, quotients (Q =CSF/serum) of SAP, CRP, and albumin and index values (Qprotein/Qalb) were calculated. The results showed no significant differences in SAP and CRP index values between control and AD subjects, although eight percent of individual AD patients showed evidence of intrathecal SAP or CRP production using the Reiber hyperbolic model. Interestingly, the SAP index value was much lower than expected, based on its molecular size. In conclusion, these data suggest that local production of SAP and CRP in the AD brain does not substantially contribute to the CSF levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930309     DOI: 10.3233/JAD-2010-100888

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  10 in total

1.  Synergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in β-amyloid generation and Alzheimer's disease.

Authors:  Anna Csiszar; Zsuzsanna Tucsek; Peter Toth; Danuta Sosnowska; Tripti Gautam; Akos Koller; Ferenc Deak; William E Sonntag; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-16       Impact factor: 4.733

2.  Acute phase response after fatal traumatic brain injury.

Authors:  Benjamin Ondruschka; Sandra Schuch; Dirk Pohlers; Heike Franke; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-01-06       Impact factor: 2.686

3.  Characterization of Cerebrospinal Fluid BACE1 Species.

Authors:  Inmaculada Lopez-Font; Claudia P Boix; Henrik Zetterberg; Kaj Blennow; Javier Sáez-Valero
Journal:  Mol Neurobiol       Date:  2019-07-09       Impact factor: 5.590

4.  Efflux transport of serum amyloid P component at the blood-brain barrier.

Authors:  Szilvia Veszelka; Judit Laszy; Tamás Pázmány; László Németh; Izabella Obál; László Fábián; Gábor Szabó; Csongor S Abrahám; Mária A Deli; Zoltán Urbányi
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-11-21

5.  Hepatic but Not CNS-Expressed Human C-Reactive Protein Inhibits Experimental Autoimmune Encephalomyelitis in Transgenic Mice.

Authors:  Tyler T Wright; Rachel V Jimenez; Todd E Morgan; Namrata Bali; Xiaogang Hou; Mark A McCrory; Caleb E Finch; Alexander J Szalai
Journal:  Autoimmune Dis       Date:  2015-09-03

6.  Dementia in the older population is associated with neocortex content of serum amyloid P component.

Authors:  Stephan Ellmerich; Graham W Taylor; Connor D Richardson; Thais Minett; Amand Floriaan Schmidt; Carol Brayne; Fiona E Matthews; Paul G Ince; Stephen B Wharton; Mark B Pepys
Journal:  Brain Commun       Date:  2021-10-09

7.  Plasma proteins predict conversion to dementia from prodromal disease.

Authors:  Abdul Hye; Joanna Riddoch-Contreras; Alison L Baird; Nicholas J Ashton; Chantal Bazenet; Rufina Leung; Eric Westman; Andrew Simmons; Richard Dobson; Martina Sattlecker; Michelle Lupton; Katie Lunnon; Aoife Keohane; Malcolm Ward; Ian Pike; Hans Dieter Zucht; Danielle Pepin; Wei Zheng; Alan Tunnicliffe; Jill Richardson; Serge Gauthier; Hilkka Soininen; Iwona Kłoszewska; Patrizia Mecocci; Magda Tsolaki; Bruno Vellas; Simon Lovestone
Journal:  Alzheimers Dement       Date:  2014-07-08       Impact factor: 21.566

8.  Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease.

Authors:  Frederic Brosseron; Andreas Traschütz; Catherine N Widmann; Markus P Kummer; Pawel Tacik; Francesco Santarelli; Frank Jessen; Michael T Heneka
Journal:  Alzheimers Res Ther       Date:  2018-02-26       Impact factor: 6.982

Review 9.  Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside.

Authors:  Mario Di Napoli; Mark Slevin; Aurel Popa-Wagner; Puneetpal Singh; Simona Lattanzi; Afshin A Divani
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

Review 10.  IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer's disease: Systematic Review and Meta-Analysis.

Authors:  Ada Ng; Wilson W Tam; Melvyn W Zhang; Cyrus S Ho; Syeda F Husain; Roger S McIntyre; Roger C Ho
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.